This article is more than 5 years old. Information may no longer be current.
Mount Sinai Beth Israel appoints neurosurgery chair
Click Here to Manage Email Alerts
Constantinos G. “Costas” Hadjipanayis, MD, PhD, has been named professor and chair of the department of neurosurgery at Mount Sinai Beth Israel.
Hadjipanayis — a surgical neuro-oncologist — also has been appointed director of neurosurgical oncology for Mount Sinai Health System and director of the brain tumor nanotechnology laboratory at Tisch Cancer Institute.
Constantinos G. “Costas” Hadjipanayis
“I am delighted to welcome this rising star to the leadership team at Mount Sinai Beth Israel, where he will oversee growth and development of neurosurgery at this important hospital” Joshua Bederson, MD, chairman of neurosurgery for Mount Sinai Health System, said in a press release. “Costas brings passion, innovation, and extraordinary talent to our superb team of brain tumor surgeons.”
Hadjipanayis is recognized as a neuro-oncology pioneer, leading cooperative group- and industry-sponsored clinical trials for patients with malignant brain tumors. His interests include surgery and experimental therapeutics for malignant brain tumors, neuro-endoscopy for pituitary tumors and colloid cysts. He also performs microsurgery and radiosurgery for tumors of the skull base and spinal cord.
Prior to joining Mount Sinai, Hadjipanayis served as associate professor in the department of neurosurgery at Emory University School of Medicine, chief of neurosurgery at Emory University Hospital Midtown, and director of the Winship Brain Tumor Center of Emory. He also served as president of the Georgia Neurosurgical Society and Southeastern Brain Tumor Foundation.